Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: One thought that comes to mind-LL,

I do believe when the Js were first taken to court, we were talking two or three hundred million. Correct me please. But whatever that number was, it was based on the assumption that we will be licensing downstream. If the Supreme Court rules that you can not double dip, then how much money would TPL/PTSC lose? Considering the size of Toshiba's and Matsushita's downstream customers, I would venture to say at least double what we were originally asking for, perhaps much more than that. A significant amount for sure. So the Supreme Court contingency certainly is logical IMHO. Opty

Share
New Message
Please login to post a reply